Testicular germ cell tumors (TGCT) are the most frequent cancer among young men, with increasing incidence worldwide. Advanced paternal age has been linked to adverse health outcomes in offspring, but reports on the association of paternal age with TGCT are few and inconsistent. We aimed to examine the relationship of paternal age (PAB) at birth with the risk of TGCT and by histologic type: seminoma and non-seminoma. A population-based cohort of 1,056,058 males, examined at ages 16-19 between the years 1980-2011, was linked to the Israel National Cancer Registry to obtain incident TGCT through 2012. We applied multivariable Cox regression. During 16.5 million person-years of follow-up, 1247 incident cases (604 seminomas and 643 non-seminomas) were detected. Increasing PAB was linearly associated with lower risk of TGCT (HR per year = 0.983, 95% CI: 0.974-0.993, p = 0.001), after adjustment for year of birth, years of education, height, cryptorchidism history and origin, and also with additional adjustment for maternal age at birth (MAB) (HR per year = 0.980: 0.965-0.995, p = 0.008). The association was stronger for seminoma (HR per year = 0.968: 0.946-0.989, p = 0.004) and persisted in a subset adjusted for sibship size (HR per year = 0.950: 0.917-0.983, p = 0.003). In the fully adjusted model, young PAB (15-24 vs. ≥30) was a risk factor for seminoma (HR = 1.41: 1.07-1.85, p = 0.014). In models adjusted for PAB, MAB was not associated with risk of TGCT. In conclusion, our findings suggest that young paternal age is a risk factor of TGCT, especially seminoma. The findings warrant further investigation into the possible impact of young paternal age on their offsprings' testes.
INTRODUCTION
Testicular germ cell tumors (TGCT) are the most common cancer among young men (Znaor et al., 2014) . The incidence of TGCT has increased in many countries, including Israel (Huyghe et al., 2003) . It is hypothesized that TGCT originates in very early life, consistent with the Developmental Origins of Health and Disease (DOHaD) paradigm (Walker & Ho, 2012; Skakkebaek et al., 2016) , possibly as part of the testicular dysgenesis syndrome (Juul et al., 2014) . TGCT are commonly grouped into two main histologic types, seminomas and non-seminomas, each representing roughly half of diagnosed cases. The most consistent risk factors for both seminoma and non-seminoma are a previous history of TGCT including in situ, a family history of TGCT, cryptorchidism , and adult height (Lerro et al., 2010) . There are very limited and conflicting on paternal age at birth (PAB) or maternal age at birth (MAB) and risk of TGCT ). The most recent study found young PAB as a risk factor for seminoma (Cook et al., 2008) . The authors concluded that there is need for well-powered and histologically stratified studies to further elucidate risk factors for TGCT.
We conducted a large-scale population-based cohort study to examine the relationship of PAB with the risk of TGCT overall and by histologic type. age 17, before military service. This permits design of a largescale population-based cohort study of Israeli male adolescents followed to adulthood. Our study population included those examined since January 1, 1980, the first year with nearly complete data on PAB, until December 31, 2011. We included Jewish males aged [16] [17] [18] [19] [irrespective of whether they were actually drafted into service or not] and excluded men without PAB data (N = 40,567) or with PAB ≤ 14 (N = 234) or PAB ≥ 90 (N = 19) which are likely to be erroneous, as PAB was our primary independent variable. We excluded men with a cancer diagnosis (N = 2286) prior to examination at age 17 (since 1960), those of Ethiopian origin (N = 19,512) who differ in their phenotypic and genetic characteristics from those of North African origin, and 24 subjects without two testicles. The study protocol was approved by the Ethics Committee of the Israel Defense Force Medical Corps, which waived the requirement for informed consent.
Data sources and variables
Socio-demographic (based on official records) and anthropometric data and a documented medical history were obtained at the recruitment centers, and a physical examination was undertaken by physicians during the obligatory call-up. PAB and MAB were defined as the difference between paternal or maternal year of birth and the participant's year of birth as only year of birth was available for the parents. PAB and MAB were treated as variables in single-year increments. MAB age ≤12 (N = 75) or ≥55 (N = 734) were classified as missing. To allow comparison with a prior study (Cook et al., 2008) , we also created a PAB variable grouped into three categories (<25, 25-29, ≥30, the oldest group serving as the reference).
Origin/place of birth was defined by country of birth, grouped to Western (including Europe, the Americas, Australia, and Southern Africa), Asia, and North Africa for immigrants to Israel, and by paternal country of birth for the Israeli born, as previously described . Consequently, seven categories were formed as follows: Western born; Asian born; North African born; Israeli born, Western origin; Israeli born, Asian origin; Israeli born, North African origin; and Israeli born, Israeli origin. Years of schooling prior to military service were grouped into ≤9, 10, 11, and ≥12 years of education. Height and weight were measured by trained medical personnel using a stadiometer and a beam balance. A routine examination of the genitalia was conducted by a qualified physician as part of the general screening physical examination required to determine military fitness (Rais et al., 2013) . Following the examination and collection of the medical history from the primary care provider, a specific code was given to participants with history of cryptorchidism or orchiopexy (hereafter 'cryptorchidism history').
Sibship size (at time of examination) and birth order data were available only for a subset of recruits numbering 510,940 examined in 1996-2010. Sibship size and birth order were grouped into four categories (1, 2, 3, ≥4), similar to other studies (Swerdlow et al., 1987; Cook et al., 2008) . Additional grouping was to small sibship size (1-3 siblings) and large sibship size (≥4 siblings).
Cases of cancer in our cohort were identified by linkage to the Israel National Cancer Registry (INCR) by way of the unique personal identification number given to all Israeli citizens at birth or immigration. The INCR, a population-based registry in operation since 1960, meets internationally accepted requirements for the coding system (ICD-O-version 3) and completeness of data. Reporting is mandatory by Israeli law since 1982. Completeness for solid tumors is high (94%) and has maintained consistently high coverage since its inception in the 1960s (Iscovich et al., 1998) .
Histologically verified TGCT, histologic type seminoma and non-seminoma, registered between 1980 and 2012, the last year with data at the time of linkage, were included in the study. Only primary tumors, ICD-O topography code C62.9 (Testis NOS), C62.0 (undescended testis), and C62.1 (descended testis) were included. Diagnoses were grouped as seminoma (morphologic codes 9060-9062, 9064, excluding spermatocytic seminoma; McGlynn et al., 2007) or non-seminoma [including embryonal carcinoma, codes 9070-9073; malignant teratoma (including mixed tumors), codes 9080-9085 and 9102; choriocarcinoma, codes 9100-9101; and non-seminomatous GCT, code 9065], as in other studies (Bray et al., 2006) .
Statistical methods
We described characteristics of the overall study population and by PAB categories using means AE standard deviation (SD) for continuous variables and proportions (%) for categorical variables. Cox proportional hazard modeling was used to assess the association between PAB (continuous or categorical) or MAB, each separately as well as jointly, and time to TGCT diagnosis and by histologic type, seminoma or non-seminoma. Follow-up was censored when any cancer diagnosis was recorded or by the end of study period, whichever came first. Models were repeated with a quadratic term for PAB. Year of birth was associated with the incidence of TGCT. Consequently, we introduced year of birth as a variable in single-year increments into all 'univariable' models. We previously reported that year of birth, years of education (only for seminoma), height, and origin were significant predictors of seminoma and non-seminoma in our population and were consequently adjusted for in the multivariable models. All multivariable models were also adjusted for cryptorchidism history as a covariate, as cryptorchidism is a known risk factor for TGCT ). Similar models were used with further adjustment for sibship size and birth order (which were available only for a subset). 95% confidence intervals (CI) were computed for the hazard ratios (HR). Inspection of log minus log plots for each variable verified the assumption of proportionality of the hazards. We performed analyses with IBM SPSS version 21.
RESULTS
Altogether, 1,056,058 Jewish Israeli males were eligible for the study, with mean age at examination of 17.3 years. Mean (SD) PAB in years was 31.4 (6.2), and mean MAB was 27.8 (5.4). The correlation of PAB and MAB was expectedly high (Pearson r = 0.776). Offspring of fathers aged 15-24 (vs. ≥25) years at birth (11% of the population) were less educated (25% vs. 18% did not complete 12 years of education) and had lower birth order and smaller sibship (Table 1) .
During a mean (SD) follow-up of 15.6 (8.7) years, constituting 16.5 million person-years, 1247 cases of TGCT were reported to the INCR: 604 seminoma and 643 non-seminoma (Table S1 ). The mean (SD) age at diagnosis was 31.3 (6.2) and 27.1 (5.8), for seminoma and non-seminoma, respectively, higher for seminoma by 4.2 (95% CI: 3.5-4.8) years. Mean (SD) PAB was 30.1 (5.8) and 30.8 (6.0) for the group with seminoma or non-seminoma, respectively. The mean PAB was lower by 0.9 (95% CI: 0.6-1.3) among the group with TGCT compared to TGCT-free group and lower by 0.7 (95% CI 0.1-1.4) among the group with seminoma compared to the group with non-seminoma.
Paternal age at birth and MAB were each inversely associated with TGCT, in analyses adjusting for year of birth, and after additionally controlling for years of education, height, cryptorchidism history, and origin (Table 2) . However, associations were stronger for seminoma than for non-seminoma, both in models adjusted for year of birth and for fully adjusted models (Table 3) .
In the multivariable separate adjusted model, both increasing PAB (HR per year = 0.974, 95% CI: 0.961-0.988, p < 0.001) and MAB (HR per year = 0.981: 0.966-0.997, p = 0.017) predicted lower risk of seminoma but not of non-seminoma (for PAB, HR per year = 0.992: 0.979-1.005, p = 0.069). In the multivariable model of PAB adjusted for MAB, the association of PAB with seminoma persisted (HR per year = 0.968: 0.946-0.989, p = 0.004), whereas that of MAB was attenuated (HR per year = 1.010: 0.985-1.035, p = 0.44). A quadratic term for PAB did not improve the fit of the model.
Paternal age at birth introduced as a categorical variable showed a graded association with TGCT, primarily driven by the association with seminoma (Table 4) , adjusting for MAB and other covariates, with the highest risk evident in the youngest PAB age group (15-24 years, HR for TGCT = 1.23: 1.01-1.50, p = 0.042; HR for seminoma = 1.41: 1.07-1.85, p = 0.014), intermediate for PAB of 25-29 years (HR for TGCT = 1.13: 0.98-1.32, p = 0.098; HR for seminoma = 1.18: 0.95-1.46, p = 0.14) compared to PAB of ≥30 years reference group.
A history of cryptorchidism was strongly associated with risk of TGCT (HR = 3.48: 2.26-5.36, p < 0.001), showing a somewhat stronger association with seminoma (HR = 4.36: 2.52-7.36, p < 0.001) than with non-seminoma (HR = 2.62: 1.31-5.27, p = 0.007), in the models adjusted for both PAB and MAB. Results for association with PAB or MAB were unchanged with removal of cryptorchidism history as a covariate in the models (data not shown).
Data on sibship size and birth order were available for a subset of our cohort, examined between 1996 and 2010 [N = 510,940, 136 seminoma cases, 230 non-seminoma cases] (Table 5 ). In the fully adjusted model adjusted for the same covariates, small sibship size (1-3 siblings compared with sibship size ≥4) was associated with increased risk of seminoma (HR = 1.76: 1.17-2.66, p = 0.006), but not of non-seminoma. Birth order was not associated with seminoma or non-seminoma. The association between PAB and risk of seminoma persisted strongly in this subset after adding sibship size to the fully adjusted model (HR per year = 0.950: 0.917-0.983, p = 0.003). Results for PAB were similar for a model adjusted for birth order or both sibship size and birth order (data not shown).
DISCUSSION
In this large population-based cohort of 1 million Israeli men, we found that men born to younger fathers had an increased risk TGCT, especially seminomas. The association was linear; for each increasing year of paternal age, the risk of seminoma decreased by 3.2%. The risk for seminoma was 40% higher for offspring of a father aged 15-24 at their birth compared to offspring of a father aged ≥30. The association was independent of maternal age, year of birth, years of education, height, origin, cryptorchidism history, and sibship size or birth order. Maternal age, after adjustment for paternal age, was not associated with risk of TGCT overall, or by histologic type. In a systematic literature review (Table S2) , we found eight studies which examined the association between PAB and TGCT, three of which differentiated seminoma and non-seminoma. Richiardi et al. (2004) found in a nested case-control study a slightly higher risk for TGCT for young PAB (adjusted OR 1.13 (0.98-1.31) comparing <25 vs. 25-29 years) but did not report risk by histologic type (1143 of 3051 TGCT cases were seminoma). Among other case-control studies, in two studies, there was no significant association between PAB and TGCT (Henderson et al., 1979; Moller & Skakkebaek, 1997) , and in two studies that only reported mean PAB among TGCT cases and controls, the difference was not statistically significant (Dieckmann et al., 2001) , or not reported (Aschim et al., 2008) . In the studies that also assessed the association with seminoma, English et al. (2003) reported in a case-control study an adjusted odds ratio of 1.01 (0.98-1.03) per year of PAB for seminoma. There is only one previous cohort study on PAB and TGCT, which did not find a significant association between PAB and TGCT or seminoma, but this study lacked power (N = 183 for seminoma and only five cases in the youngest PAB category) (Westergaard et al., 1998) . Cook et al. (2008) found in a case-control study of US servicemen that young PAB is risk factor for TGCT (adjusted OR = 1.45: 1.08-1.94) or seminoma (adjusted OR = 1.53: 1.03-2.27), both for <25 vs. 25-29), consistent with the current study. The current study was based on a cohort with adequate power to examine the association between PAB and seminoma, controlling for possible confounders.
There is limited research on PAB and offspring health, mainly regarding the association of advanced PAB with offspring outcomes, such as tumors (Ramasamy et al., 2015) . The link is better established for psychiatric disorders such as autism (Reichenberg et al., 2006) and schizophrenia (Frans et al., 2011) . Recent studies suggest that epigenetic differences in paternal spermatozoa may explain offspring phenotypes (Feinberg et al., 2015) . Increasing PAB was found to be associated with reduced fecundity (Ford et al., 2000) , as well as higher risk of spontaneous abortion (Slama et al., 2005) . A recent meta-analysis found age-associated declines in parameters indicating semen quality, particularly DNA fragmentation (Johnson et al., 2015) . Goriely and others suggested that dysregulation in spermatogonial cell behavior may be the common factor in the paternal age effect disorders (Goriely & Wilkie, 2012) , with a possibility of a process termed selfish spermatogonial selection (Maher et al., 2016) . Another possible mechanism of PAB impact on offspring health and testicular development could be through sperm telomere length. Sperm telomere length increases with age, and offspring of older fathers tend to have longer telomeres in their spermatozoa (Kimura et al., 2008; Ferlin et al., 2013) . The association between sperm telomere length and PAB was hypothesized to result from a paternal age-dependent germ stem cell selection process, based on a twin study (Hjelmborg et al., 2015) . Table 2 Cox proportional hazard ratios (HR) for risk of TGCT by paternal and/or maternal age at birth in 1,056,058 Israeli men examined as adolescents from 1980 to 2011 and followed up through 2012, 'univariable' adjusted and multivariable adjusted models Eisenberg suggested that the paternal effect on telomeres might be an adaptive signal of the expected age of male reproduction in the environment offspring were born into (Eisenberg, 2011) .
There is some evidence that testicular germ cell tumors, and other manifestations of testicular dysgenesis syndrome, originate in early life (Juul et al., 2014) . Possible explanations for higher risk of seminoma among men born to younger fathers include shorter telomere length and differences in paternal age-dependent germ cell selection, possibly through telomere length or epigenetic changes, reducing the probability of conception of fetuses who will develop seminoma among older, but not younger fathers. Further research on the role in offspring testicular development of young and older PAB and PAB-associated sperm characteristics such as telomere length or epigenetic differences is warranted. Specific attention should be devoted to development of the male reproductive system in the offspring, in animal and/or human models.
The study may direct attention to potential problems currently associated with young paternal age, although public health implications of this single study require a broader overview of health outcomes, beyond TGCT. While there is growing attention to the possibility of adverse effects of advanced paternal age (Jennings et al., 2017) , young paternal age is a neglected public health problem (Sander & Rosen, 1987) , and potential adverse effects of young paternal age are rarely studied. In contrast, young maternal age is a known public health challenge (Klein, 2005) , and there is some evidence for potential adverse impacts on offspring health (Stewart et al., 2007) .
Studies, varied in design, population, and power, found inverse, direct or no association between MAB and TGCT risk , and a meta-analytic synthesis of 14 studies did not find such association . While most studies reported findings for seminoma and non-seminoma combined, findings from stratified analysis sometimes showed heterogeneity (but sometimes did not), which suggests etiologic differences between seminoma and non-seminoma (Richiardi et al., 2002) . In our study, MAB seemed to be associated with seminoma, but not non-seminoma. However, this association disappeared after controlling for PAB.
The association between small sibship size and TGCT risk was first reported by Swerdlow et al. (1987) . A meta-analysis found a significant higher risk of TGCT for a sibship size of 1 compared to ≥4 . The association with sibship size might reflect higher risk of seminoma among subfertile couples (Richiardi et al., 2004) . Previous studies and a meta-analysis found an inverse association between birth order and risk of testicular cancer . The direction of association with birth order and with small sibship size was similar in our study, especially for seminoma, but findings are limited by the lower statistical power we had for examining this association.
Strengths of our large cohort study include its prospective population-based design, its representativeness of Jewish male 17-year-olds in our population reflecting the mandatory health examination, high statistical power, high degree of completeness of the cancer registry data throughout study period, including data on histologic type, and the ability to adjust for multiple possible confounders. Table 4 Cox proportional hazard ratios (HR) for risk of TGCT (N = 1247), seminoma (N = 604) or non-seminoma (N = 643) by paternal age at birth categories, in 1,056,058 Israeli men examined from 1980 to 2011 and followed up through 2012, multivariable adjusted models Limitations of our study include a shorter period of follow-up for the more recent birth cohorts. However, as TGCT is predominantly diagnosed during young adulthood, predictors are expected to be similar in magnitude. We did not have information on a family history of TGCT. Exploring PAB as a risk factor might be complicated by its correlation with MAB. However, we did not find evidence for multicollinearity and the association of PAB with seminoma was strong with or without MAB in the model.
In conclusion, we found higher risk TGCT, especially seminomas, for men born to younger fathers. This finding warrants further investigation into the possible roles of young paternal age in the developmental origins of TGCT.
